08/02/19 05:17:18 YwAPn1Nx
>>204 APPのヘパリン増産体制の為にFDAが検査承認の迅速化などの配慮をしている
The FDA acted quickly to approve the new APP production lines because of the
specter of a looming national shortage of the blood-thinning medication, used
in millions of heart operations and kidney dialysis center procedures each year.